In the wake of the Diamond Action Plan for Biotech Takeoff, the government's drafting of the Biotech and New Pharmaceutical Development Statute and signing of the Economic Cooperation Framework Agreement (ECFA) and Cross-strait Cooperation Agreement on Medicine and Public Health Affairs with China will expand collaboration opportunities for the biotech industries in Taiwan and China, bring future market opportunities, and induce domestic and foreign firms to sharply increase their investment in the biotech industry.Furthermore, as demographic aging continues worldwide, healthcare reform in numerous countries and the continued growth of emergency markets will increase demand for pharmaceuticals and medical products,creating more opportunities for the biotech industry. In view of this background, the Diamond Action Plan for Biotech Takeoff will enable industry to take advantage of upstream R&D results and technologies at an early date, promote the establishment and development of R&D-oriented pharmaceutical and medical devices companies, attract investment by international capital, and transform Taiwan into a major biotech hub providing foreign firms with convenient access to the Asian market.

Abstract The biotechnology industry, include a series of new technologies, is recognized as a star industry in the 21st century by the countries all over the world. The development of these new technologies may drive another wave of industry upgrading and make the whole economic development in the future. In our ten major new industry, three items belong to biotechnology industry: pharmacy, health care and pollution prevention industry. Among them, the pharmacy industry, in large economic scale, Europe and American usually grasp the advantage and leading right all the time. And the native country pharmacy industry of Taiwan, occupies the inferior position, is unable to compete with it. Stem from the difference of the national habits, the health food product in Taiwan are researched and launched in higher speed than the advanced countries. So, if we can develop the health food industry with the biotechnology, we will have advantages. According to internationalized angle, we will have certain advantages not only in cost, resource, relatively free of economic scale, but also in the technological level of the industry, lead other relatively countries of the backward areas. This research finds we have to learn the way of Western medicine marketing skill at present, with ' academic marketing ' and ' evidence marketing ' , to develop the health food industry. Company in Taiwan should be a main operations objective by mould out the corporate image with high professional engineering leveling instead of consuming a large amount of fixed cost and time. Shorten enterprise balanced time to come is the most important thing. Never spend all money before ¡¥ Dream Come True ¡¥! This research proposes the following development tactics for reference: (1) Lock Chinese market, expand and sell in other areas actively. (2) Seeking the foreign capitals for strategic alliance and expanding the department scale of operation with more plural structure. (3) Shorten the time of research and develop the innovative products and maintain the position with leading technology of industry by the cooperation with college. (4) Implement the staff's study and growth, keep enterprise's running and growing up steadily , mould enterprise's high-quality image and create enterprise's brand intangible assets value forever. (5) Pay attention to external environment condition , regulation environment and overall influence of management environment at any time. ( 6) Lower costs in order to improve the competitiveness continuously. And continuously cahnge the products structure to make a profit to improve enterprises.